Form 4: IonQ's Chief Revenue Officer Rima Alameddine Executes Stock Sales Under 10b5-1 Plan
SEC Form 4 Filing
Rima Alameddine, Chief Revenue Officer of IonQ, Inc., executed sales of common stock on October 11 and 14, 2024, under a pre-arranged Rule 10b5-1 trading plan.
Summary
- Rima Alameddine, the Chief Revenue Officer of IonQ, Inc., reported the sale of IonQ common stock.
- The sales occurred on October 11 and October 14, 2024.
- These transactions were executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 7, 2024.
- On October 11, 2024, 716 shares were sold at a price of $10.72 per share.
- On October 14, 2024, 9,159 shares were sold at a price of $10.72 per share.
- Following these transactions, Alameddine directly owns 648,783 shares of IonQ common stock.
Sentiment
Score: 5
Explanation: The document is neutral as it reports routine stock sales under a pre-arranged trading plan. It doesn't inherently indicate positive or negative sentiment.
Risks
- Executive stock sales can sometimes be perceived negatively by investors, potentially leading to speculation about the company's future prospects, although sales under a 10b5-1 plan are typically pre-scheduled and less likely to be based on insider information.
Industry Context
Sales by company executives are a normal part of corporate activity. The use of a 10b5-1 trading plan is a common practice to avoid insider trading accusations, allowing insiders to sell shares at predetermined times and prices.
Comparison to Industry Standards
- Executive compensation packages often include stock options and grants, leading to periodic sales.
- The use of 10b5-1 plans is a standard practice among publicly traded companies to ensure compliance with insider trading regulations.
- Comparable companies such as Rigetti Computing and D-Wave Systems also see periodic filings related to executive stock transactions.
Stakeholder Impact
- Shareholders may react to the news of executive stock sales, although the existence of a 10b5-1 plan mitigates concerns about insider information.
Key Dates
| Date | Description |
|---|---|
| March 7, 2024 | Date the reporting person adopted the Rule 10b5-1 trading plan |
| October 11, 2024 | Date of the first reported transaction: sale of 716 shares of common stock |
| October 14, 2024 | Date of the second reported transaction: sale of 9,159 shares of common stock |
| October 15, 2024 | Date of the signature on the Form 4 filing |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.